$1,471.40 travel Payment -- Teva Pharmaceuticals to Dr. Gregory Evans
Teva Pharmaceuticals covers $1471.40 in travel for Pain Management physician Gregory Evans
This page provides a detailed analysis of a $1,471.40 travel payment from Teva Pharmaceuticals to Dr. Gregory Evans. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $1,471.40 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Gregory Evans |
| NPI Number | 1283933401 |
| Physician Specialty | Pain Management |
| Location | City, IN |
| Date of Payment | 2026-02-04 |
| Related Drug/Device | Revlimid |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $1.5K travel payment to Gregory Evans, a Pain Management specialist in City, IN. The payment was associated with Revlimid. The payment of $1471.40 to Dr. Gregory Evans by Teva Pharmaceuticals on February 4, 2026, was for travel and lodging related to Revlimid. This payment represents a moderate financial interaction between the pharmaceutical company and a physician in Pain Management. The specific nature of the travel and lodging is not detailed, but it is associated with a specific drug, Revlimid.
Patient Guidance: What This Payment Means for You
If your doctor receives travel or lodging support from a drug company, it's usually to help them learn about new treatments or attend educational events. Always discuss your treatment options directly with your doctor. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for travel and lodging to Pain Management physicians can vary, but this amount is moderate and typical for educational events or consultations related to specific medications.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act's reporting requirements, which mandate disclosure of financial relationships between drug manufacturers and healthcare providers.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- pain-management
- revlimid
- open-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $1.5K payment for?
This was a travel payment of $1.5K from Teva Pharmaceuticals to Gregory Evans, categorized as "Travel and Lodging". It was associated with Revlimid. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Gregory Evans accept pharmaceutical money?
Yes, Gregory Evans received this $1.5K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Gregory Evans's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $1.5K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Pain Management?
To compare this payment against Pain Management averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pain Management physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Gregory Evans's relationship with Teva Pharmaceuticals?
The payment amount is specific and itemized as travel and lodging. This $1.5K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Pain Management?
The payment is linked to a particular drug, Revlimid.
What should patients do after learning about this payment?
If your doctor receives travel or lodging support from a drug company, it's usually to help them learn about new treatments or attend educational events. Always discuss your treatment options directly with your doctor.
What else should I know about this travel payment?
The physician's specialty is Pain Management, which may have specific interactions with pharmaceutical companies.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.